Two American pharmaceutical giants reported earnings this morning, both showing flagging sales – but one ended the day with a gain. Merck & Co. Inc. (NYSE: MRK) shares gained 1.05% to close at $58.58 while Pfizer Inc. (NYSE: PFE) …
PFE closed Tuesday's trading at $35.69 ... TTNP closed Tuesday's trading at $0.80, down 4.63%. In after-hours, the stock was up 25% to $1.00. Xenon Pharmaceuticals Inc. (XENE) has announced positive interim data from its ongoing phase …
Tara Clarke: Pfizer Inc. (NYSE:PFE) will soon feel the pressure from the wave of lawsuits being filed claiming that Pfizer’s blockbuster drug Lipitor – the world’s best-selling drug of all time – causes type-2 diabetes in women. With a market ...
The stock is expected to list on the Nasdaq Global Market under ... The company plans to use the proceeds to fund a phase 3 clinical trial, for milestone payments to Pfizer Inc. PFE, +0.10% and for general corporate purposes. Iterum is …
It better hurry, Spark and Pfizer (PFE) are also collaborating on a hemophilia treatment ... Cowen & Co's Ritu Baral also recently initiated coverage on the …
Meanwhile, Walmart Inc (NYSE:WMT) added 1.21% or 1.01 points to end at …
Since being spun off from Pfizer Inc (PFE.N) in 2013, Zoetis has carried out a major restructuring that saw the company shed a quarter of its workforce and several …
Soriot, who saw off a 2014 takeover bid from Pfizer (PFE.N) in part by promising annual sales of $45 ... results from a lung cancer immunotherapy trial dubbed Mystic. The stock has since rallied, helped by good news from two other studies.
Diane Alter: The Pfizer stock price is up 0.5% today as the U.S. drug giant remains in advanced stages to buy Allergan Plc. (NYSE:AGN). Pfizer Inc. (NYSE:PFE) is pushing forward with the deal despite the best wishes of the U.S. …
PFE closed Monday's trading at $36.80 ... PRTA closed Monday's trading at $11.50, down 68.78%. In after-hours, the stock was up 0.87% to $11.60.